VC9 - No 9 Construction Join Stock Company (HNX:VC9)

Ligand Pharmaceuticals Statistics

Total Valuation

HNX:VC9 has a market cap or net worth of VND 68.45 billion. The enterprise value is 139.42 billion.

Market Cap	68.45B
Enterprise Value	139.42B

Important Dates

The last earnings date was Thursday, July 24, 2025.

Earnings Date	Jul 24, 2025
Ex-Dividend Date	n/a

Share Statistics

HNX:VC9 has 16.70 million shares outstanding. The number of shares has increased by 8.40% in one year.

Current Share Class	16.70M
Shares Outstanding	16.70M
Shares Change (YoY)	+8.40%
Shares Change (QoQ)	-0.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 104.26.

PE Ratio	104.26
Forward PE	n/a
PS Ratio	0.38
PB Ratio	1.07
P/TBV Ratio	1.08
P/FCF Ratio	n/a
P/OCF Ratio	48.40
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	209.23
EV / Sales	0.78
EV / EBITDA	18.39
EV / EBIT	21.23
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.13.

Current Ratio	1.02
Quick Ratio	0.47
Debt / Equity	1.13
Debt / EBITDA	9.50
Debt / FCF	n/a
Interest Coverage	1.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	3.00%
Revenue Per Employee	3.59B
Profits Per Employee	13.33M
Employee Count	50
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.89% in the last 52 weeks. The beta is 0.13, so HNX:VC9's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-8.89%
50-Day Moving Average	4,160.00
200-Day Moving Average	4,403.50
Relative Strength Index (RSI)	45.78
Average Volume (20 Days)	46,580

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HNX:VC9 had revenue of VND 179.30 billion and earned 666.35 million in profits. Earnings per share was 39.33.

Revenue	179.30B
Gross Profit	15.29B
Operating Income	6.57B
Pretax Income	666.35M
Net Income	666.35M
EBITDA	7.58B
EBIT	6.57B
Earnings Per Share (EPS)	39.33

Balance Sheet

The company has 1.06 billion in cash and 72.03 billion in debt, giving a net cash position of -70.97 billion or -4,251.06 per share.

Cash & Cash Equivalents	1.06B
Total Debt	72.03B
Net Cash	-70.97B
Net Cash Per Share	-4,251.06
Equity (Book Value)	63.79B
Book Value Per Share	3,821.01
Working Capital	9.58B

Cash Flow

Operating Cash Flow	1.41B
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 8.53%, with operating and profit margins of 3.66% and 0.37%.

Gross Margin	8.53%
Operating Margin	3.66%
Pretax Margin	0.37%
Profit Margin	0.37%
EBITDA Margin	4.23%
EBIT Margin	3.66%
FCF Margin	n/a

Dividends & Yields

HNX:VC9 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.40%
Shareholder Yield	n/a
Earnings Yield	0.97%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HNX:VC9 has an Altman Z-Score of 0.16 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.16
Piotroski F-Score	3